| Disease | multiple myeloma |
| Comorbidity | C0376545|hematologic cancer |
| Sentences | 1 |
| PubMedID- 24249729 | Melphalan (mel) is widely used to treat patients with hematologic cancer, including multiple myeloma, but its mechanism of action in ebv-transformed b cells is poorly described. |
Page: 1